Osama M. Ashour

1.0k total citations
34 papers, 820 citations indexed

About

Osama M. Ashour is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Osama M. Ashour has authored 34 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Pathology and Forensic Medicine and 6 papers in Rheumatology. Recurrent topics in Osama M. Ashour's work include Biochemical and Molecular Research (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers) and Folate and B Vitamins Research (5 papers). Osama M. Ashour is often cited by papers focused on Biochemical and Molecular Research (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers) and Folate and B Vitamins Research (5 papers). Osama M. Ashour collaborates with scholars based in Saudi Arabia, Egypt and United States. Osama M. Ashour's co-authors include Ashraf B. Abdel‐Naim, Essam Abdel‐Sattar, Abdulmohsin J. Alamoudi, Thikryat Neamatallah, Ahmed M. Al‐Abd, Ayman A. Nagy, Ahmed A. Elberry, Ahmed M. Mohamadin, Hisham A. Mosli and Mohamed Ibrahim and has published in prestigious journals such as Biochemical Pharmacology, European Journal of Pharmacology and Food and Chemical Toxicology.

In The Last Decade

Osama M. Ashour

31 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Osama M. Ashour Saudi Arabia	14	250	180	147	113	99	34	820
Yanfei Xin China	19	404 1.6×	178 1.0×	106 0.7×	63 0.6×	99 1.0×	39	875
Eman M. Mantawy Egypt	17	234 0.9×	209 1.2×	144 1.0×	127 1.1×	63 0.6×	27	817
Wesam M. El‐Bakly Egypt	15	329 1.3×	267 1.5×	211 1.4×	156 1.4×	78 0.8×	29	1.2k
Michał B. Ponczek Poland	20	272 1.1×	79 0.4×	73 0.5×	81 0.7×	169 1.7×	53	1.2k
Ebtehal El‐Demerdash Egypt	15	195 0.8×	127 0.7×	98 0.7×	278 2.5×	63 0.6×	25	771
Pei‐Ming Chu Taiwan	18	380 1.5×	80 0.4×	76 0.5×	57 0.5×	69 0.7×	31	910
Lamiaa El-Shennawy Egypt	9	221 0.9×	59 0.3×	148 1.0×	177 1.6×	60 0.6×	13	654
Jin Chen China	19	594 2.4×	100 0.6×	238 1.6×	110 1.0×	105 1.1×	86	1.3k
Ying Yin China	19	496 2.0×	91 0.5×	80 0.5×	87 0.8×	56 0.6×	45	1.1k
Xin Han China	20	460 1.8×	54 0.3×	87 0.6×	124 1.1×	74 0.7×	59	1.1k

Countries citing papers authored by Osama M. Ashour

Since Specialization

Citations

This map shows the geographic impact of Osama M. Ashour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osama M. Ashour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osama M. Ashour more than expected).

Fields of papers citing papers by Osama M. Ashour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osama M. Ashour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osama M. Ashour. The network helps show where Osama M. Ashour may publish in the future.

Co-authorship network of co-authors of Osama M. Ashour

This figure shows the co-authorship network connecting the top 25 collaborators of Osama M. Ashour. A scholar is included among the top collaborators of Osama M. Ashour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osama M. Ashour. Osama M. Ashour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alamoudi, Abdulmohsin J., et al.. (2025). 2-Methoxyestradiol alleviates E. coli-induced endometritis in rats via inhibition of TLR-4/MyD88/NF-κB axis. European Journal of Pharmacology. 1005. 178101–178101.

Alamoudi, Abdulmohsin J., Nabi Shah, Saif Ullah, et al.. (2024). Diuretic effects of Hecogenin and Hecogenin acetate via aldosterone synthase inhibition. Saudi Pharmaceutical Journal. 32(7). 102105–102105. 2 indexed citations

Azhar, Ahmad S., et al.. (2020). 2-Methoxyestradiol ameliorates metabolic syndrome-induced hypertension and catechol-O-methyltransferase inhibited expression and activity in rats. European Journal of Pharmacology. 882. 173278–173278. 8 indexed citations

Abdel‐Naim, Ashraf B., Thikryat Neamatallah, Basma G. Eid, et al.. (2018). 2‐Methoxyestradiol Attenuates Testosterone‐Induced Benign Prostate Hyperplasia in Rats through Inhibition of HIF‐1α/TGF‐β/Smad2 Axis. Oxidative Medicine and Cellular Longevity. 2018(1). 4389484–4389484. 31 indexed citations

Al‐Abd, Ahmed M., Abdulmohsin J. Alamoudi, Ashraf B. Abdel‐Naim, Thikryat Neamatallah, & Osama M. Ashour. (2017). Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies – A review. Journal of Advanced Research. 8(6). 591–605. 158 indexed citations

Algandaby, Mardi M., et al.. (2017). Icariin protects against thioacetamide-induced liver fibrosis in rats: Implication of anti-angiogenic and anti-autophagic properties. Pharmacological Reports. 69(4). 616–624. 41 indexed citations

Algandaby, Mardi M., Ali M. El‐Halawany, Hossam M. Abdallah, et al.. (2016). Gingerol protects against experimental liver fibrosis in rats via suppression of pro-inflammatory and profibrogenic mediators. Naunyn-Schmiedeberg s Archives of Pharmacology. 389(4). 419–428. 28 indexed citations

Aly, Hamdy A.A., Nagla A. El‐Shitany, Hesham A. El-Beshbishy, & Osama M. Ashour. (2013). Ameliorative effect of lycopene against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced rat liver microsomal toxicity. Toxicology and Industrial Health. 31(10). 938–950. 8 indexed citations

Abdallah, Hossam M., et al.. (2013). Protective effect of Centaurea pallescens Del. against CCl4-induced injury on a human hepatoma cell line (Huh7). Medicinal Chemistry Research. 22(12). 5700–5706. 7 indexed citations

10.

Elberry, Ahmed A., Jaudah Al‐Maghrabi, Essam Abdel‐Sattar, et al.. (2011). Anti-inflammatory and antiproliferative activities of date palm pollen (Phoenix dactylifera) on experimentally-induced atypical prostatic hyperplasia in rats. Journal of Inflammation. 8(1). 40–40. 57 indexed citations

11.

Ashour, Osama M., et al.. (2011). Changes in nitric oxide and free radical levels in rat gastrocnemius muscle during contraction and fatigue. Clinical and Experimental Pharmacology and Physiology. 38(12). 791–795. 10 indexed citations

12.

Elberry, Ahmed A., Ashraf B. Abdel‐Naim, Essam Abdel‐Sattar, et al.. (2010). Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats. Food and Chemical Toxicology. 48(5). 1178–1184. 98 indexed citations

13.

Algandaby, Mardi M., et al.. (2010). Mechanisms of the antihyperglycemic activity of Retama raetam in streptozotocin-induced diabetic rats. Food and Chemical Toxicology. 48(8-9). 2448–2453. 43 indexed citations

14.

Ibrahim, Mohamed, et al.. (2009). Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity. Pharmacological Research. 60(5). 373–381. 116 indexed citations

15.

Mohamadin, Ahmed M., et al.. (2008). MELATONIN PROTECTS AGAINST HYDROGEN PEROXIDE‐INDUCED GASTRIC INJURY IN RATS. Clinical and Experimental Pharmacology and Physiology. 36(4). 367–372. 12 indexed citations

16.

Khalifa, Mohamed Mansour, et al.. (2006). Investigation of the Mechanisms Underlying the Gastroprotective Effect of Nicorandil. Pharmacology. 79(2). 76–85. 5 indexed citations

17.

Ashour, Osama M., Omar N. Al Safarjalani, Fardos N.M. Naguib, et al.. (2000). Modulation of plasma uridine concentration by 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase: relevance to chemotherapy. Cancer Chemotherapy and Pharmacology. 45(5). 351–361. 13 indexed citations

18.

Ashour, Osama M., et al.. (2000). Modulation of 5-fluorouracil host toxicity by 5-(benzyloxybenzyl)barbituric acid acyclonucleoside, a uridine phosphorylase inhibitor, and 2′,3′,5′-tri-O-acetyluridine, a prodrug of uridine. Biochemical Pharmacology. 60(3). 427–431. 11 indexed citations

19.

Ashour, Osama M., Fardos N.M. Naguib, Naganna M. Goudgaon, Raymond F. Schinazi, & Mahmoud H. el Kouni. (2000). Effect of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on plasma concentration of uridine released from 2′,3′,5′-tri- O -acetyluridine, a prodrug of uridine: relevance to uridine rescue in chemotherapy. Cancer Chemotherapy and Pharmacology. 46(3). 235–240. 6 indexed citations

20.

Ashour, Osama M., Fardos N.M. Naguib, & Mahmoud H. el Kouni. (1996). 5-(m-Benzyloxybenzyl)barbituric acid acyclonucleoside, a uridine phosphorylase inhibitor, and 2′,3′,5′-tri-o-acetyluridine, a prodrug of uridine, as modulators of plasma uridine concentration. Biochemical Pharmacology. 51(12). 1601–1611. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact